In one paragraphArticle in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 2 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
6 authors at 2 institutions in 1 country.
Kelsey L KrusDepartment of Developmental Biology, Washington University School of Medicine, St. Louis, United States, 63110.ORCID 0000-0002-4425-2141 Ana Morales BenitezDepartment of Developmental Biology, Washington University School of Medicine, St. Louis, United States, 63110.ORCID 0000-0002-1021-5262 Amy StricklandDepartment of Genetics, Washington University School of Medicine, St. Louis, United States, 63110.ORCID 0000-0002-5809-8464 Jeffrey MilbrandtDepartment of Genetics, Washington University School of Medicine, St. Louis, United States, 63110.ORCID 0000-0002-5477-7689 A Joseph BloomDepartment of Genetics, Washington University School of Medicine, St. Louis, United States, 63110.ORCID 0000-0002-6731-5539 Aaron DiAntonioDepartment of Developmental Biology, Washington University School of Medicine, St. Louis, United States, 63110.ORCID 0000-0002-7262-0968 Washington University in St. Louis · USJames S. McDonnell Foundation · US
Funding
WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8MDISSECTION OF SARM1-INDUCED AXON DEGENERATION AND CELL DEATHR01NS087632 · NINDS · WASHINGTON UNIVERSITY · PI Aaron Diantonio, JEFFREY D MILBRANDT · 2014 to 2026
$6.4MRegulation of axonal degeneration by the DLK kinaseR37NS065053 · NINDS · WASHINGTON UNIVERSITY · PI Aaron Diantonio · 2020 to 2026
$4.3MSARM1 functional polymorphisms and their contribution to ALS riskR01NS119812 · NINDS · WASHINGTON UNIVERSITY · PI BLOOM, ADAM JOSEPH, DIANTONIO, AARON · 2021 to 2025
$2.9MRegulating NAD Metabolism to Inhibit Axon Degeneration in Neurodegenerative DiseasesRF1AG013730 · NIA · WASHINGTON UNIVERSITY · PI MILBRANDT, JEFFREY D · 2017 to 2017
$2.8MNCATS NIH HHS UL1 TR002345NIA NIH HHS RF1 AG013730NINDS NIH HHS R01 NS087632NINDS NIH HHS R01 NS119812NINDS NIH HHS R37 NS065053
6 · The paper itselfAbstract
Pathological TDP-43 loss from the nucleus and cytoplasmic aggregation occurs in almost all cases of ALS and half of frontotemporal dementia patients.
Indexed as
ALSFTDneurodegenerationneuropathyStathminSTMN2TARDBPTDP-43
Identifiers
PMID38562780
PMCPMC10983882
OpenAlexW4393053980
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390